ConductScience.org, home

Paper33008372

Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system.

Walweel K and 26 others. J Biomed Sci, 2020. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system. Papers, record 33008372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33008372

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system.
PubMed
Journal
J Biomed Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2021-05-25
PubMed

Authors27

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Walweel KKhttps://orcid.org/0000-0003-1866-5767
2Skeggs KK
3Boon ACA C
4See Hoe LEL E
5Bouquet MM
6Obonyo NGN G
7Pedersen SES E
8Diab SDS D
9Passmore MRM R
10Hyslop KK
11Wood ESE S
12Reid JJ
13Colombo SMS M
14Bartnikowski NJN J
15Wells MAM A
16Black DD
17Pimenta LPL P
18Stevenson AKA K
19Bisht KK
20Marshall LL

Source PubMed

See all 27 authorsDownload CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endothelin Receptor AntagonistsMajor topic
LungMajor topic
PyridinesMajor topic
Respiratory Function TestsMajor topic
TetrazolesMajor topic
Vasodilator AgentsMajor topic
Animals
Disease Models, Animal
Perfusion
Sheep, Domestic
Tissue Donors

Source PubMed

Download CSV of topics

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110193365Improving donor lung evaluation: a new approach to increase organ supply for lung transplantation.Thorax1998https://conductscience.org/library/papers/10193365PubMed
215987392Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C.Crit Care2005https://conductscience.org/library/papers/15987392PubMed
320005351Brain death and its influence on the lungs of the donor: how is it prevented?Transplant Proc2009https://conductscience.org/library/papers/20005351PubMed
424015344Preclinical pulmonary capillary endothelial dysfunction is present in brain dead subjects.Pulm Circ2013https://conductscience.org/library/papers/24015344PubMed
522453765Ex vivo adenoviral vector gene delivery results in decreased vector-associated inflammation pre- and post-lung transplantation in the pig.Mol Ther2012https://conductscience.org/library/papers/22453765PubMed
627514498Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation.Transpl Int2016https://conductscience.org/library/papers/27514498PubMed
711966665Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects.Br J Clin Pharmacol2002https://conductscience.org/library/papers/11966665PubMed
89620935Efficacy of administering an endothelin-receptor antagonist (SB209670) in ameliorating ischemia-reperfusion injury in lung allografts.Am J Respir Crit Care Med1998https://conductscience.org/library/papers/9620935PubMed
922459036Effects of brain death on organ quality and transplant outcome.Transplant Rev (Orlando)2012https://conductscience.org/library/papers/22459036PubMed
1020494026Suppression of inflammatory cytokines during ex vivo lung perfusion with an adsorbent membrane.Ann Thorac Surg2010https://conductscience.org/library/papers/20494026PubMed
1126730551Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs.Am J Transplant2016https://conductscience.org/library/papers/26730551PubMed
1216143257Endothelin-1 receptor antagonist prevents deterioration of left ventricular function and coronary flow reserve in brain-dead canine heart.J Heart Lung Transplant2005https://conductscience.org/library/papers/16143257PubMed
1317062004Time-dependent changes in donor brain death related processes.Am J Transplant2006https://conductscience.org/library/papers/17062004PubMed
1415530195Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.Pediatr Crit Care Med2004https://conductscience.org/library/papers/15530195PubMed
1523288125Ex vivo lung reconditioning: a new era for lung transplantation.J Bras Pneumol2012https://conductscience.org/library/papers/23288125PubMed
1621488765Normothermic ex vivo lung perfusion in clinical lung transplantation.N Engl J Med2011https://conductscience.org/library/papers/21488765PubMed
1719025532The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.Acta Anaesthesiol Scand2008https://conductscience.org/library/papers/19025532PubMed
1824783206Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care.Biomed Res Int2014https://conductscience.org/library/papers/24783206PubMed
1926755269Deceased Organ Donation.Am J Transplant2016https://conductscience.org/library/papers/26755269PubMed
2019268801History of solid organ transplantation and organ donation.Crit Care Clin2009https://conductscience.org/library/papers/19268801PubMed

See all 69 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
40837549Contributions, bias, and research gaps in large animal ex vivo lung perfusion models: A systematic review.JHLT Open2025https://conductscience.org/library/papers/40837549PubMed
35649110Ex-vivo lung perfusion therapies: do they add value to organ donation?Curr Opin Organ Transplant2022https://conductscience.org/library/papers/35649110PubMed
35178130Endothelin-Converting Enzyme 1 and Vascular Endothelial Growth Factor as Potential Biomarkers during Ex Vivo Lung Perfusion with Prolonged Hypothermic Lung-Sparing.Dis Markers2022https://conductscience.org/library/papers/35178130PubMed
34666219Brain stem death induces pro-inflammatory cytokine production and cardiac dysfunction in sheep model.Biomed J2022https://conductscience.org/library/papers/34666219PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33008372

GET https://conductscience.org/api/papers/v1/33008372/authors?page=2